| Today's Open | $72.60 |
|---|---|
| Previous Close | $73.12 |
| Daily Range | $71.89 - $73.31 |
| 52-Week Range | $53.88 - $75.73 |
| Market Cap | $176.7B |
| P/E Ratio | 18.80 |
| Dividend (Yield) | $2.53 (2.8%) |
| Ex-Dividend Date Dividend Pay Date |
02/26/13 04/05/13 |
| Volume | 990,418 |
| Average Daily Volume | 1,430,310 |
| Current FY EPS | $5.11 |
Sector
Healthcare
Industry
Drugs
Novartis (NVS) Description
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products. Website: http://www.novartis.com/
News & Commentary
This Blockbuster Biologic May Face a Steep Cliff
Neulasta generated sales north of $4 billion for Amgen in 2012, but generic competition is brewing on two continents.Positive Data on Novartis' Jakavi - Analyst Blog
Positive Data on Novartis' Jakavi - Analyst Blog3 Humongous Health-Care Stocks This Week
These stocks skyrocketed this week. But will gravity soon kick in?Encouraging Data on Novartis' Gilenya - Analyst Blog
Encouraging Data on Novartis' Gilenya - Analyst Blog1 Thing You Always Wanted to Know About Drugs (but Were Afraid to Ask)
Two fascinating approaches pharmaceutical companies use to discover new drugs.NVS's Top Competitors
(-1.67%)
(-1.74%)
(-0.36%)
(-1.89%)